Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer

Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer

Tumor vaccines offer a number of advantages for cancer treatment. In the study, the vaccination with cancer stem cells (CSCs) with high expression of the type I receptor tyrosine kinase-like orphan receptor (ROR1) was evaluated in a murine model for the vaccine’s immunogenicity and protective effica...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Wu, Xiaoyu Yu, Jing Wang, Xu Hui, Yunxia Zhang, Yunlang Cai, Mulan Ren, Mei Guo, Fengshu Zhao, Jun Dou
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/9394615
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items